On April 6, 2018, Prof. Howard Lee gave a special lecture on the principles of clinical trials to visitors from Syntekabio Inc.. They were Dr. Tyson Kim, CEO, Dr. HyunJin Yang, and 4 interns (medical and pharmacy students). Syntekabio Inc. is a South Korean bioinformatics venture firm focusing on genome integration based on big data analysis through the innovative use of artificial intelligence technology. The lecture was followed by an extensive and lively discussion among all the participants, including CCADD members. Tyson Kim also shared his experiences and perspective on the pharmaceutical industry in terms of using bioinformatics technology to streamline drug development. It was a unique opportunity to broaden knowledge beyond the academy. Both CCADD and Syntekabio expect to have more opportunities like this one to advance both party's interests in a collaborative way.